求購(gòu)米力農(nóng)注射液質(zhì)量標(biāo)準(zhǔn)JX20090327   [更多]

1、https://www.sciencedirect.com/science/article/pii/S0022354917307177 2、Justus Liebigs Annalen der Chemie, 1907, vol. 351, p. 319 3、Efficacy and tolerability of amlodipine in patients with stable angina pectoris: an open-label, multicenter trial Volume 59, Issue 4, April 1998, Pages 215-222 4、Efficacy and safety of perindopril arginine + amlodipine in hypertension Journal of the American Society of Hypertension Volume 9, Issue 4, April 2015, Pages 266-274 5、Sprifermin shows cartilage-protective effects in knee OA 6、Justus Liebigs Annalen der Chemie, 1907, vol. 351, p. 319 7、Quantitation of cytokine levels in skin graft donor site wound fluid. Grayson LS1, Hansbrough JF, Zapata-Sirvent RL, Dore CA, Morgan JL, Nicolson MA. 8、Preparation of tadalafil analogues as antiparasitic agents 9、https://academic.oup.com/mmy/article-abstract/57/2/181/4909416?redirectedFrom=fulltext 10、https://jamanetwork.com/journals/jamadermatology/article-abstract/557354 11、Bioequivalence assessment of Fumatifen? tablet to Zaditen? tablet (ketotifen fumarate 1 mg) by liquid chromatography tandem mass spectrometry 12、Pharmacokinetics of ketotifen after oral administration to healthy male subjects 13、Optimal medical management of peripheral arterial disease. Rice TW, Lumsden AB. Vasc Endovascular Surg. 2006 Aug-Sep;40(4):312-27. Review. 14、Treatment of small hepatocellular carcinomas 15、CIMETIDINE, THE IMMUNE SYSTEM, AND CANCER 16、Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial 17、https://www.karger.com/Article/Abstract/236401 18、Reaction of enamines and mediated anodic oxidation of carbohydrates with the 2,2,6,6-tetramethylpiperidine-1-oxoammonium ion (TEMPO+) Electrochimica Acta, Volume 50, Issues 25–26, 5 September 2005, Pages 4956-4972 19、An improved HPLC method for determination of nifuratel in human plasma and its application to pharmacokinetics studies XL   [更多]

求購(gòu)利丙雙卡因乳膏（恩納）信息   [更多]

我公司需要查詢一個(gè)信息   [更多]

詳細(xì)要求： 需求名稱：美沙拉秦腸溶片注冊(cè)標(biāo)準(zhǔn) 具體要求：0.25g和0.5g規(guī)格最新版本 要求時(shí)間：請(qǐng)?jiān)?020年11.20之前 交稿方式：直接點(diǎn)擊交稿在線交稿就是了，我會(huì)每天過(guò)來(lái)看的，謝謝各位藥智的戰(zhàn)友們   [更多]

需求內(nèi)容在圖片里面   [更多]

①?gòu)娜蝿?wù)主手中獲取指定年報(bào)數(shù)量的年報(bào)文件（PDF） ②將年報(bào)中“利潤(rùn)或合并利潤(rùn)”、“研發(fā)或研發(fā)投入”、“行業(yè)產(chǎn)品地區(qū)收入”、“治療領(lǐng)域”、“產(chǎn)銷量”、“產(chǎn)品研發(fā)投入明細(xì)”等數(shù)據(jù)填入相應(yīng)表格中（任務(wù)主提供填寫模板） ③要求仔細(xì)認(rèn)真，有責(zé)任心。 ④價(jià)格3.5元/份年報(bào)預(yù)計(jì)100份，一人完成，共計(jì)350。 ⑤若審核發(fā)現(xiàn)有錯(cuò)填、漏填，以每漏填，錯(cuò)填一個(gè)數(shù)據(jù)1元計(jì)量扣除賞金 ⑥以前合作做過(guò)類似項(xiàng)目的優(yōu)先考慮，如有感興趣的威客可聯(lián)系參與   [更多]

具體要求： ①?gòu)娜蝿?wù)主手中獲取指定年報(bào)數(shù)量的年報(bào)文件（PDF） ②將年報(bào)中“利潤(rùn)或合并利潤(rùn)”、“研發(fā)或研發(fā)投入”、“行業(yè)產(chǎn)品地區(qū)收入”、“治療領(lǐng)域”、“產(chǎn)銷量”、“產(chǎn)品研發(fā)投入明細(xì)”等數(shù)據(jù)填入相應(yīng)表格中（任務(wù)主提供填寫模板） ③要求仔細(xì)認(rèn)真，有責(zé)任心。 ④價(jià)格3.5元/份年報(bào)預(yù)計(jì)100份，一人完成，共計(jì)350。 ⑤若審核發(fā)現(xiàn)有錯(cuò)填、漏填，以每漏填，錯(cuò)填一個(gè)數(shù)據(jù)1元計(jì)量扣除賞金 ⑥以前合作做過(guò)類似項(xiàng)目的優(yōu)先考慮，如有感興趣的威客可聯(lián)系參與   [更多]

求購(gòu)吸入用乙酰半胱氨酸溶液進(jìn)口藥學(xué)資料   [更多]

求購(gòu)鹽酸戊乙奎醚注射液質(zhì)量標(biāo)準(zhǔn)pdf版，國(guó)藥準(zhǔn)字H20193271、國(guó)藥準(zhǔn)字H20203005、國(guó)藥準(zhǔn)字H20203004、國(guó)藥準(zhǔn)字H20203003的質(zhì)量標(biāo)準(zhǔn)，不必四個(gè)都要。   [更多]